Latuda (Lurasidone Hcl) Rx Price Comparison: US vs Canada — Save Up to 83% in the US

Our most recent US pharmacy data shows a low of roughly $18.13 for Lurasidone Hcl with a standard discount card. That figure moves with dosage and quantity — check the comparison table for the exact combination you need.

Yes — Cost Plus Drugs lists Lurasidone Hcl at roughly $0.071 per unit, a published price with no membership card or coupon involved. See the three-price comparison above for how that stacks up against discount-card pharmacies.

We found Canadian pricing for Lurasidone Hcl starting near $0.410 per tablet in USD terms. That's before any shipping charge, which the table above breaks out separately.

Drug pricing is set separately in each country through different negotiation, regulatory, and distribution systems, so the same medication can legitimately carry different price tags on either side of the border. In this case, our data shows the US price is actually the lower of the two once a program like Cost Plus Drugs is factored in — the assumption that Canada is always cheaper doesn't hold for every drug.

Your out-of-pocket cost for Latuda with insurance depends entirely on your specific plan's formulary and benefit structure. As a brand-name drug, Latuda is often placed on a higher formulary tier, which may result in higher copays or coinsurance. Some plans may also require prior authorization or that you try other medications first. To understand your coverage, contact your insurance provider's member services department or speak with your pharmacist.

Latuda may be covered by Medicare Part D prescription drug plans, but coverage details and patient costs differ significantly from one plan to another. You should check directly with your plan to confirm coverage and your expected copay or coinsurance amount. Your pharmacist can also provide a price check based on your Medicare plan information. If your out-of-pocket cost remains high, you can inquire about the price using other pharmacy savings options.

Latuda is the brand name for lurasidone, an atypical antipsychotic medication. It is FDA-approved for the treatment of schizophrenia and for depressive episodes associated with bipolar I disorder (bipolar depression). It is thought to work by affecting the activity of serotonin and dopamine receptors in the brain, which can help alleviate symptoms of these conditions.